|
|
Volumn 22, Issue 3, 1992, Pages 529-532
|
|
Keynote address: Concepts and developments in radiosensitization of mammalian cells
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (2 BROMOETHYLAMINO) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL;
1 AZIRIDINO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL;
ETANIDAZOLE;
METAL DERIVATIVE;
METRONIDAZOLE;
MISONIDAZOLE;
MITOMYCIN C;
NIMORAZOLE;
NITRO DERIVATIVE;
PIMONIDAZOLE;
PORFIROMYCIN;
RADIOSENSITIZING AGENT;
TIRAPAZAMINE;
RADIATION SENSITIZING AGENTS;
CELL KILLING;
DNA DAMAGE;
DRUG EFFICACY;
EDITORIAL;
GASTROINTESTINAL TOXICITY;
GLIOBLASTOMA;
HUMAN;
HYPOXIC CELL;
INTRAVENOUS DRUG ADMINISTRATION;
IRRADIATION;
MAMMAL CELL;
NAUSEA;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PHARYNX TUMOR;
PHASE 1 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RADIOSENSITIZATION;
RADIOTHERAPY;
SQUAMOUS CELL CARCINOMA;
UTERINE CERVIX CANCER;
VOMITING;
ANIMAL;
CELL CULTURE;
CELL HYPOXIA;
DRUG EFFECT;
IN VITRO STUDY;
PHYSIOLOGY;
RADIATION DOSE;
RADIATION EXPOSURE;
REVIEW;
ANIMAL;
CELL HYPOXIA;
HUMAN;
IN VITRO;
RADIATION TOLERANCE;
RADIATION-SENSITIZING AGENTS;
TUMOR CELLS, CULTURED;
|
|
EID: 0026491324
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/0360-3016(92)90868-I Document Type: Article |
|
Times cited : (14)
|
|
References (6)
|
